Tevimbra by BeiGene for Gallbladder Cancer: Likelihood of Approval

Tevimbra is under clinical development by BeiGene and currently in Phase II for Gallbladder Cancer.

M&A: Orbita Acquires Wellbe Assets

What You Should Know: Orbita today announced it has acquired the assets of Wellbe, a digital health company providing patient navigation for specialty care. The

August 18, 2023

Prior COVID Infection May Protect Against Some Common Colds

If you’ve been sick with COVID-19, you may have some protection against certain versions of the common cold. A new study suggests previous COVID-19 infections

June 14, 2024

Gallbladder cancer incidence declines overall but increases among Black Americans

Gallbladder cancer rates have been stable or declining for most Americans over the last two decades, but cases have steadily risen among Blacks, with growing

May 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.